Objective: The aim of this study was to investigate whether infusion of bombesin, when combined with a gastric preload, in¯uence satiety and foot intake in obese and lean healthy women. Design: Double blind, placebo controlled study. Setting: Department of Gastroenterology, Leiden University Medical Center, The Netherlands. Subjects: Obese (n 7) and lean (n 7) healthy women. Interventions: Intravenous infusion of bombesin (0.09 nmol/kg ideal weight/h) or placebo for 165 min.
Introduction
The tetradecapeptide bombesin, originally isolated from the skin of the European amphibian Bombina Bombina, and its mammalian counterpart gastrin releasing peptide (GRP) are neurotransmitters in¯uencing several gastrointestinal functions. In fact, infusion of these polypeptides stimulates gastric and pancreatic secretion and in¯uences intestinal motility. Infusion of bombesin also induces the release of several gastrointestinal hormones including gastrin and cholecystokinin (CCK) in several species including man (Green et al, 1989; De Magistris et al, 1981; Jansen & Lamers, 1983a) . CCK induces satiety and decreases food intake in man (Kissileff et al, 1981; Pi-Sunyer et al, 1982) . It has also been demonstrated that bombesin, like CCK, induces feeding suppression in a variety of species, when administered intravascularly, intraperitoneally or intraventricularly (Muurahainen et al, 1983; Hostetler et al, 1989; Gibbs & Smith, 1988; Bado et al, 1989; McCoy & Avery, 1990; . The effect of CCK on food intake is dependent on the amount of food previously eaten (Muurahainen et al, 1991) . After ®lling of the stomach with a preload, CCK infusion reduces food intake more stronger than without a preload. Recently we have shown that bombesin reduces food intake in lean women (Lieverse et al, 1993a) but the effect was less pronounced in obese women (Lieverse et al, 1994) . Since a gastric preload enhances satiety we have investigated whether (1) bombesin induces feeding depression and in¯uences satiety when combined with a gastric preload and (2) there are differences in eating behavior and satiety in response to bombesin combined with the preload between lean and obese women.
Subjects and methods
Seven healthy obese women (age 43 AE 3 y, body mass index of 39 AE 2.0 kg/m 2 ) and seven for age and sex matched healthy lean women (age 42 AE 3 y, body mass index 22 AE 0.3 kg/m 2 ) were studied. None of the subjects had a history of gastrointestinal, cardiac or pulmonary disease or was taking medication. Informed consent was obtained from each individual. The protocol had been approved by the human ethics committee of the Leiden University Medical Center.
After an overnight fast the volunteers presented to our laboratory at 08.00 am. Two intravenous cannulas were inserted in the antecubital vein of both forearms, one for infusion of either bombesin or saline and the other for blood sampling. Saline or bombesin (bombesin 0.25 nmol/ kg ideal weight/165 min) were infused through an intravenous catheter in a randomized double blind fashion. For ideal weight in lean subjects their actual weight was used and for obese subjects ideal weight was calculated by subtracting 100 from their length in cm. In previous investigations we have shown that this calculation of infusion dose resulted in comparable plasma hormone levels between lean and obese subjects (Lieverse et al, 1993b) . Infusions were started at 09.00 am. The two studies were performed in random order and separated from each other by an interval of at least one week. The females were investigated on days irrespective of their time in the menstrual cycle. Sixty minutes after the start of the saline or bombesin infusion, a banana-shake consisting of 100 g of mixed banana slices, supplemented to 300 ml with water (132 kcal) was served and consumed within 3 min. Fifteen min later, at t 75 min, a solid meal of banana slices, containing 1 g/100 g protein 0 g/100 g fat and 32 g/100 g carbohydrates was served in abundance. The meal was weighed before and afterwards to determine the exact amount of food consumed.
Subjective criteria like desire to eat, hunger feeling, fullness and prospective feeding intentions (Blundell & Burley, 1987; Silverstone, 1982) were scored on 100 mm visual analogue scales basally and at 15 min intervals until 60 min after the end of the infusion period. For each subject the scores at the start of the study, at time 0 min, were de®ned as zero and served as reference point. Changes in subjective satiety scores during the test procedure are given as decreases or increases over basal (time 0 min). Questions asked were: How strong is your desire to eat? (very weak or very strong); how hungry do you feel? (not hungry at all or as hungry as I have ever felt); how full do you feel? (not at all full or very full); how much food do you think you could eat? (nothing or very much). The subjects also indicated on visual analogue scales whether they appreciated the meal.
Fifteen min before the infusion (t minus 15), 15 min before the banana-shake (at t 45), 15 min after the meal (at t 90), at t 120 min, t 165 min (end of the infusion) and at t 225 min (end of the experiment) a list and photograph showing six protein-rich, six fat-rich, six carbohydrate-rich (each about 200 kcal) and six low energy items were presented (food selection lists). For each of these 24 items the subjects were asked if they wanted to eat at that moment the whole amount, the double amount, half the amount or nothing, independent of the other items. At each time interval the total amount of caloric items was calculated (half the amount 1 2 caloric item, double the amount 2 caloric items). Plasma CCK and bombesin concentrations were measured by sensitive and speci®c radioimmunoassays as described previously (Jansen & Lamers, 1983b; De Jong et al, 1987) .
Statistical analysis
Results are given as mean AE s.e.m. Differences in satiety scores between the bombesin and control experiment were analyzed by comparing the integrated incremental area under the curve of satiety scores before the preload (from 0±60 min) and after the meal (from 75±225 min) using Wilcoxon's matched pairs signed rank test. Differences in food intake (amount eaten in g) between bombesin and control were analyzed using Wilcoxon's matched pairs signed rank test. Differences in satiety scores and food intake between lean and obese subject were analyzed using Mann Whitney's test. Differences in plasma CCK and bombesin levels during bombesin infusion were analyzed by ANOVA. When this indicated a probability of less than 0.05 for the null hypothesis, Student Newman Keuls analyses were performed to determine which values differed signi®cantly. The signi®cance level was set at P`0.05.
Results

Food intake
During bombesin infusion food intake in lean subjects (193 AE 37 g) was signi®cantly less than during saline infusion (365 AE 42 g, P`0.05). In obese subjects, however, no signi®cant differences in food intake between bombesin (241 AE 46 g) and saline infusion (301 AE 45 g) were found. Furthermore the decrease in food intake during bombesin infusion compared to saline infusion was signi®cantly greater in lean (173 AE 30 g) than in obese subjects (59 AE 35 g; P`0.05).
Satiety scores
Bombesin induced a signi®cant (P`0.05) satiety effect before ingestion of the preload (from 0±60 min) in the lean but not in the obese women (Figures 1 and 2 ; Table 1 ). Bombesin signi®cantly (P`0.05) decreased the preprandial wish to eat, hunger feelings and prospective feeding intentions and increased feelings of fullness in the lean women (integrated satiety scores from 0±60 min; Table 1 ). Ingestion of the meal at time 75 min signi®cantly (P`0.05) affected satiety scores as shown by a reduction in wish to eat, hunger, prospective feeding and an increase in fullness from 75±90 min (end of the meal). These changes occurred in lean and obese women both during bombesin and saline infusion. Postprandially the satiety scores gradually returned towards baseline both in lean and obese women and no signi®cant differences were observed between bombesin and saline infusion, neither in lean nor in obese women. Analyzing the food selection lists, bombesin induced a signi®cant subjective preprandial satiety effect in lean women (P`0.05) but not in obese. This satiety effect in lean women was speci®c for protein-rich products. Postprandially no signi®cant differences in satiety effects between bombesin and saline were found neither in obese nor in lean women (data not shown).
Plasma hormone levels
During saline infusion no bombesin was detected in plasma. During bombesin infusion plasma bombesin levels were around 50 pM. Plasma bombesin levels during bombesin infusion were not signi®cantly different between lean and obese women; the area under the curve from 0 min till 165 min was 4594 AE 800 pM.165 min in lean and 5020 AE 722 pM.165 min in obese women (Figure 3) .
Mean basal plasma CCK levels were signi®cantly lower in obese (2.4 AE 0.2 pM) than in lean women (3.2 AE 0.1 pM, P`0.05). During bombesin infusion there was a signi®cant increase in plasma CCK in both lean and obese subjects to 6.8 AE 1.5 pM and 7.4 AE 1.6 pM respectively. Thereafter plasma CCK levels gradually decreased during continuous infusion of bombesin, but remained signi®cantly (P`0.05) elevated over basal until the end of bombesin infusion both in lean and obese women. The integrated incremental CCK secretion during bombesin infusion was comparable for lean (263 AE 121 pM/ 165 min) and obese women (220 AE 39 pM/165 min; Figure 4 ).
Both lean and obese women appreciated bananas equally (59 AE 9 and 65 AE 7 mm on 100 mm VAS scales respectively). None of the subjects experienced nausea or other abdominal symptoms during bombesin infusion. The duration of meal ingestion during bombesin infusion was for lean (4.0 AE 0.5 min) and obese women (4.6 AE 0.6 min) signi®cantly shorter than during saline infusion (6.1 AE 0.6 min for lean and 7.3 AE 0.8 min for obese individuals; P`0.05).
Discussion
Our results show that the neuropeptide bombesin, when infused in doses that stimulate CCK secretion to postprandial plasma CCK levels , induces satiety in lean but not obese women. When combined with a gastric preload bombesin signi®cantly reduces food intake but only in lean and not in obese women.
The mechanism(s) by which bombesin induces satiety are poorly understood. It is unlikely that bombesin exerts its effect as a circulating hormone (Gibbs & Smith, 1988; McCoy & Avery, 1990) . Bombesin potently stimulates CCK secretion and CCK is considered a satiating agent. However, recently we and others have shown that bombesin acts independent of CCK to reduce food intake (Lieverse et al, 1993a,c; Stein & Woods, 1981) . The effect of bombesin infusion on satiety is not antagonized during CCK receptor blockade with loxiglumide (Lieverse et al, 1993a,c) . In rats, several reports have demonstrated that the satiety effect of peripherally administered bombesin is not altered by adrenalectomy (Gibbs et al, 1981) , hypophysectomy (Stuckey et al, 1982) , arti®cially induced lesions of the hypothalamus (Geary et al, 1986) , by spinal cord section or by total subdiaphragmatic vagotomy (Stuckey et al, 1982; Smith et al, 1981) . Although neither subdiaphragmatic vagotomy nor a high thoracic spinal visceral neural disconnection affect the action of bombesin on feeding behavior, the combination of both lesions results in a complete blockade of feeding depression suggesting that the effects of peripheral administered bombesin are mediated by afferent neurocrine input (Stuckey et al, 1985) . It has further been shown that centrally administered bombesin does not produce normal satiety in rats. This ®nding suggests that the effect of peripherally administered bombesin is not produced through access of the peptide into the cerebro-spinal¯uid (Gibbs & Smith, 1988) . In baboons, however, reduction of food intake was achieved after administration of bombesin into the lateral cerebral ventricle, indicating that satiety mechanisms may be species speci®c (Figlewicz et al, 1986) . Bombesin is a potential inhibitor of gastric emptying in humans, probably due to strong contractions of the antrum and pylorus (Scarpignato et al, 1981) . This inhibition of gastric emptying may account for the satiety mechanism of bombesin in humans, although this mechanism is not operative in rats (Hostetler et al, 1989) .
Our results con®rm previous observations that bombesin induces satiety and reduces food intake in lean healthy Figure 1 Scores of subjective feelings of satiety (expressed in mm and compared to basal (time 0 min)): wish to eat, hunger, fullness and prospective feeding intentions during intravenous infusion of bombesin or saline from 0±165 min in 7 lean women. At time 60 min a banana shake (preload P) was consumed, at time 75 min ingestion of a carbohydrate meal was started (meal).
subjects (Lieverse et al, 1993a,c) . In a recent study we failed to demonstrate a satiety effect of bombesin in obese subjects (Lieverse et al, 1994) . Gastric factors are able to induce satiety. For instance the satiety effect of the neuropeptide CCK is enhanced by gastric distension (Muurahainen et al, 1991) . We hypothesized that bombesin would induce satiety in obese subjects when combining bombesin infusion with gastric distension through ingestion of a preload.
Interestingly, bombesin infusion failed to signi®cantly affect food intake and satiety in obese but otherwise healthy women, even when bombesin infusion was combined with a gastric preload. The depression of food intake by bombesin was signi®cantly greater in lean than in obese women. The reason for the discrepancy in results between lean and obese subjects is not apparent. Plasma bombesin Figure 2 Scores of subjective feelings of satiety (expressed in mm and compared to basal (time 0 min)): wish to eat, hunger, fullness and prospective feeding intentions during intravenous infusion of bombesin or saline from 0±165 min in 7 obese women. At time 60 min a banana-shake (preload P) was consumed, at time 75 min ingestion of carbohydrate meal was started (meal). Figure 3 Mean plasma bombesin levels during infusion of 0.25 nmol/ kgiw/165 min bombesin in lean and obese subjects. After 60 min a banana-shake was consumed (P) followed 15 min later by a carbohydrate-rich meal.
levels during bombesin infusion were comparable between lean and obese women. Endogenous CCK release in response to bombesin was also comparable between obese and lean subjects further indicating that the magnitude of stimulus was equal between obese and lean subjects. These data suggest that obese women are less sensitive for the satiating effects of bombesin. Studies in obese Zucker-rats, which are less sensitive for the satiating action of CCK than their lean littermates, have demonstrated that CCK binding to the pancreatic receptor is decreased in obese rats (McLaughlin & Baile, 1980; McLaughlin et al, 1984) . It is possible, but as yet unproven, that in humans the binding of bombesin to receptors involved in satiety signals is decreased in obese compared to lean subjects. This suggestion raises the question whether in obese subjects the sensitivity for other gastrointestinal peptides is also decreased. The obese mouse is less sensitive for the satiety effects of CCK and bombesin. This decreased sensitivity occurs at a very early age and is not likely to be a consequence of obesity. On the contrary, a decreased satiety may lead to larger meal size and may contribute to hyperphagia and development of obesity (McLaughlin & Baile, 1981) . Likewise it is possible that in human obesity a decreased sensitivity for satiety effects of gastrointestinal peptides occurs at a very early age and contributes to the development of obesity later in life. The stomach produces satiety after gastric distension. This signal is mediated vagally (Gonzalez & Deutsch, 1981) . Obesity is associated with autonomic disturbances, including alterations in vagal-cholinergic mechanisms (Peterson et al, 1988; Wisen et al, 1988) . This may account for the failure of the combined stimulus of bombesin with preload to affect satiety. It is concluded that infusion of bombesin, when combined with a gastric preload, inhibits food intake and increases satiety in lean but not in obese women. Obese women are less sensitive for the bombesin induced satiety effects.
